三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02197 三叶草生物-B

已收盘 09-24 16:08:29

2.060

-0.060

-2.83%

最高2.125	最低2.045	成交量148.70万
今开2.080	昨收2.120	日振幅3.77%
总市值26.76亿	流通市值26.76亿	总股本12.99亿
成交额309.06万	换手率0.11%	流通股本12.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02197","market":"HK","secType":"STK","nameCN":"三叶草生物-B","latestPrice":2.06,"timestamp":1790237309566,"preClose":2.12,"halted":0,"volume":1487000,"delay":0,"changeRate":-0.028301886792452855,"floatShares":1299000000,"shares":1299000000,"eps":-0.19005013593085815,"marketStatus":"已收盘","change":-0.06,"latestTime":"09-24 16:08:29","open":2.08,"high":2.125,"low":2.045,"amount":3090642,"amplitude":0.037736,"askPrice":2.06,"askSize":3000,"bidPrice":2.05,"bidSize":8500,"shortable":0,"etf":0,"ttmEps":0.7810983036249274,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790299800000},"marketStatusCode":5,"adr":0,"listingDate":1636041600000,"exchange":"SEHK","adjPreClose":2.12,"openAndCloseTimeList":[[1790213400000,1790222400000],[1790226000000,1790236800000]],"volumeRatio":0.589752,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02197","defaultTab":"news","newsList":[{"id":"2667161836","title":"绿地控股半年报现“广西省”等多处低级错误，董秘王晓东上任11年累计薪酬4485万","url":"https://stock-news.laohu8.com/highlight/detail?id=2667161836","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667161836?lang=zh_cn&edition=full","pubTime":"2026-09-15 13:27","pubTimestamp":1789450020,"startTime":"0","endTime":"0","summary":"从2015年至2025年公开年报薪酬统计，其任职董秘期间累计薪酬合计约4485万元。实际上，这并非绿地控股首次遭遇信息披露相关监管处罚。公开监管信息显示，2025年4月，上海证监局对公司下达责令改正措施，指出其未及时、完整披露重大诉讼事项，相关责任人被出具警示函；同年12月，上交所就债务逾期未及时披露，对公司及相关责任人予以通报批评。2026年4月，上海证监局再次对绿地控股采取责令改正监管措施。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-15/doc-inirwscy6993149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02197","BK1161","BK0028","600606","BK0012","BK0178","BK0187","BK0188","BK0196","BK0101","BK0277","BK0116"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667965362","title":"港股异动 | 三叶草生物-B(02197)午后涨超6% 呼吸道联合疫苗澳洲II期临床获积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2667965362","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667965362?lang=zh_cn&edition=full","pubTime":"2026-09-14 14:54","pubTimestamp":1789368871,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三叶草生物-B午后涨超6%。截至发稿，涨5.24%，报2.01港元，成交额548.61万港元。消息面上，三叶草生物近期宣布，其呼吸道联合疫苗候选产品SCB-1022和SCB-1033在澳大利亚老年人群中开展的II期临床试验获得积极初步数据。此外，公司已完成SCB-1022/1033相关抗原组分2000L生物反应器商业规模生产放大，并完成多个批次。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02197","BK4588","KCAI","BK1161","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667626653","title":"港股异动 | 三叶草生物-B(02197.HK)午后涨超6% 呼吸道联合疫苗澳洲II期临床获积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2667626653","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667626653?lang=zh_cn&edition=full","pubTime":"2026-09-14 14:54","pubTimestamp":1789368871,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666521629","title":"百济神州：董事王晓东减持38287股，套现约1336.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666521629","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666521629?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:31","pubTimestamp":1789126260,"startTime":"0","endTime":"0","summary":"南财智讯9月11日电，百济神州（BeOneMedicinesLtd.，纳斯达克：ONC）董事王晓东提交Form4持股变动声明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609113872228648.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609113872228648.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1969619763.USD","BK1161","BK4139","LU0307460666.USD","BK4585","BK1588","LU1770034418.SGD","BK1500","BK4526","BK1583","688235","KURE","BK0239","BK4588","LU0228659784.USD","02197","06160","LU2328871848.SGD","LU1303224171.USD","LU0828237510.HKD","LU0588546209.SGD","LU1719994722.HKD","LU1251922891.USD","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587301","title":"港股异动 | 三叶草生物-B(02197)早盘涨超9% 三叶草呼吸道联合疫苗澳洲II期获积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587301","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666587301?lang=zh_cn&edition=full","pubTime":"2026-09-09 11:04","pubTimestamp":1788923065,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三叶草生物-B早盘涨超9%。截至发稿，涨7.62%，报2.26港元，成交额1041.19万港元。消息面上，9月7日，三叶草生物公布，SCB-1022和SCB-1033在澳大利亚60-85岁老年人群中的II期临床试验获得积极初步数据。试验共入组420例受试者，接种28天后RSV中和抗体约提升6-9倍，hMPV中和抗体约提升6-8倍，未出现与疫苗相关的严重不良事件；公司同时完成了2000升商业化规模生产放大。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","VXUS","02197","KCAI","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151600976","title":"三叶草生物B轮融资：4Bio Capital领投，艾伯维风险投资、礼来等机构参投","url":"https://stock-news.laohu8.com/highlight/detail?id=1151600976","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151600976?lang=zh_cn&edition=full","pubTime":"2026-09-08 19:05","pubTimestamp":1788865554,"startTime":"0","endTime":"0","summary":"三叶草生物制药（Cloverleaf Bio）宣布完成新一轮融资，此轮融资由4Bio Capital领投。值得注意的是，艾伯维风险投资（AbbVie Ventures）与礼来公司（Eli Lilly and Company）等多家知名机构也参与了本轮投资，阵容颇为亮眼。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665360299","title":"三叶草生物-B(02197.HK)公布呼吸道联合疫苗候选产品（RSV + hMPV ± PIV3）在老年人群的澳洲 II 期临床试验获得积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2665360299","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665360299?lang=zh_cn&edition=full","pubTime":"2026-09-07 08:11","pubTimestamp":1788739916,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108460296","title":"三叶草生物公布RSV+HMPV±PIV3呼吸道联合疫苗候选产品在老年人群中的II期临床积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1108460296","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108460296?lang=zh_cn&edition=full","pubTime":"2026-09-07 07:09","pubTimestamp":1788736153,"startTime":"0","endTime":"0","summary":"三叶草生物制药今日宣布，其针对呼吸道合胞病毒与人偏肺病毒，并兼含或不含副流感病毒3型的联合疫苗候选产品，在老年受试者中开展的II期临床试验取得了积极的阶段性数据成果。值得强调的是，这组数据无疑为三叶草生物在呼吸道多联疫苗赛道的战略布局注入了强劲动力。公司表示，将进一步详析全部临床数据集，并与监管机构展开沟通，以规划后续的关键性临床开发路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195255069","title":"三叶草生物-B更新8月股份变动月报表，股本略有上升","url":"https://stock-news.laohu8.com/highlight/detail?id=1195255069","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195255069?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:57","pubTimestamp":1788512251,"startTime":"0","endTime":"0","summary":"三叶草生物制药有限公司于2026年9月4日发布2026年8月截至31日的股份变动月报表。根据公告，本月公司累计新增发行183,625股普通股，致使已发行股份由2026年7月底的1,298,417,056股增至本月末的1,298,600,681股，股本较前一月有所上升。公告显示，公司主要通过其首次公开发售前购股权计划和首次公开发售后购股权计划产生了本月新增的183,625股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662750478","title":"三叶草生物-B(02197)发布中期业绩 母公司拥有人应占利润9.55亿元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2662750478","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662750478?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:33","pubTimestamp":1787697214,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三叶草生物-B(02197)发布截至2026年6月30日止6个月业绩，该集团期内取得收入17.9万元人民币，同比减少94.5%;其他收入及收益11.12亿元，同比增加6200.94%;母公司拥有人应占利润9.55亿元，同比扭亏为盈;每股基本盈利0.75元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三叶草生物-B(02197)发布中期业绩 母公司拥有人应占利润9.55亿元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119991783","title":"三叶草生物-B（02197）公布2026年中期业绩：获一次性和解收益，上半年录得9.55亿元净利","url":"https://stock-news.laohu8.com/highlight/detail?id=1119991783","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119991783?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:16","pubTimestamp":1787696171,"startTime":"0","endTime":"0","summary":"2026年8月26日，三叶草生物-B披露截至2026年6月30日止六个月未经审核中期业绩。期内，公司实现收入179千元，同比减少94.5%；受与全球疫苗免疫联盟和解产生的一次性收益拉动，净利润由上年同期亏损1.01亿元转为盈利9.55亿元。公司表示，其他收入及收益大幅增至11.12亿元，主要源于GAVI和解协议带来的非经常性收益10.87亿元，以及汇兑收益净额。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140315169","title":"三叶草生物-B拟于8月25日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1140315169","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140315169?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:36","pubTimestamp":1786610217,"startTime":"0","endTime":"0","summary":"三叶草生物-B（02197）8月13日公告，董事会将于2026年8月25日（星期二）召开会议，主要议程包括审议并批准本公司及其附属公司截至2026年6月30日止六个月的中期业绩及其发布事宜，并考虑是否建议派付中期股息（如有）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121567407","title":"三叶草生物-B更新2026年7月股份变动月报表，股本小幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1121567407","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121567407?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:49","pubTimestamp":1785919746,"startTime":"0","endTime":"0","summary":"三叶草生物製藥有限公司于2026年8月5日披露截至2026年7月31日止的股份变动月报表。该增幅主要源于公司首次公开发售前购股权计划中4,000份购股权的行使，并因此获得认购资金约32港元。首次公开发售后购股权计划同月内失效71,500份购股权，期末剩余42,449,851份有效购股权。公司确认并无股份回购、注销或库藏股变动。截至7月底，公司已足额符合相应的最低公众持股要求。本次公告由公司董事梁朋签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652211269","title":"港股异动 | 三叶草生物-B(02197.HK)涨超5% 预计上半年扭亏为盈赚最多12.04亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652211269","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652211269?lang=zh_cn&edition=full","pubTime":"2026-07-20 11:03","pubTimestamp":1784516588,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652268610","title":"三叶草生物-B在港交所公告，本集团截至2026年6月30日止六个月预期将录得净利润约人民币9.57亿元至12.04亿元，","url":"https://stock-news.laohu8.com/highlight/detail?id=2652268610","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652268610?lang=zh_cn&edition=full","pubTime":"2026-07-20 07:16","pubTimestamp":1784503010,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1161","02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652426857","title":"三叶草生物-B(02197)发盈喜 预期中期净利润约9.57亿元至12.04亿元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2652426857","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652426857?lang=zh_cn&edition=full","pubTime":"2026-07-20 07:06","pubTimestamp":1784502397,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三叶草生物-B 发布公告，本集团截至2026年6月30日止六个月预期将录得净利润约人民币9.57亿元至12.04亿元，而去年同期则录得净亏损约人民币 1.013 亿元。撇除该收益的会计影响，本集团截至2026年6月30日止六个月预期将继续录得净亏损，主要反映本集团持续投入研发活动及缺乏重大经营收入所致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"三叶草生物-B(02197)发盈喜 预期中期净利润约9.57亿元至12.04亿元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143562010","title":"三叶草生物-B（02197）发布正面盈利预告：2026年上半年预盈9.57亿至12.04亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143562010","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143562010?lang=zh_cn&edition=full","pubTime":"2026-07-20 07:05","pubTimestamp":1784502334,"startTime":"0","endTime":"0","summary":"2026年7月20日，三叶草生物-B公告称，基于对集团截至2026年6月30日止六个月未经审计合并管理账目的初步审阅，公司预计期内将实现净利润约人民币9.57亿元至12.04亿元，而上一同期录得净亏损约人民币1.013亿元。公司指出，业绩由亏转盈主要源于全资附属公司三叶草生物制药（香港）有限公司与Gavi于2026年3月22日签订的和解协议所产生的会计收益，金额约人民币10.89亿元至13.36亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183436479","title":"三叶草生物-B预计2026年上半年净利润达9.57亿至12.04亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183436479","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183436479?lang=zh_cn&edition=full","pubTime":"2026-07-20 07:05","pubTimestamp":1784502319,"startTime":"0","endTime":"0","summary":"三叶草生物-B（股票代码：02197）发布业绩预告，预计截至2026年6月30日的六个月期间，公司净利润将介于人民币9.57亿元至12.04亿元之间。这一预测数据反映了公司在该期间内的整体财务表现预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127840401","title":"三叶草生物-B6月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1127840401","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127840401?lang=zh_cn&edition=full","pubTime":"2026-07-03 17:13","pubTimestamp":1783069986,"startTime":"0","endTime":"0","summary":"三葉草生物製藥有限公司于2026年7月3日发布截至2026年6月30日的股份变动月报表。报告显示，公司在报告期内各项股本数据保持稳定，未发生新增发行、回购或注销活动。报告期末已发行的普通股数量为1,298,413,056股，亦无增减变化，库藏股期末数目为零。三葉草生物製藥有限公司确认已遵守香港联合交易所有限公司《上市规则》及相关法律和监管规定。此次月报由公司董事梁朋签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186053321","title":"三叶草生物-B公布5月股份变动月报 新增发行179,252股","url":"https://stock-news.laohu8.com/highlight/detail?id=1186053321","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186053321?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:37","pubTimestamp":1780475825,"startTime":"0","endTime":"0","summary":"三叶草生物制药有限公司于2026年6月3日披露截至2026年5月31日的股份变动月报表。公告显示，本期法定/注册股本及面值均未发生变化，至2026年5月底，公司注册股本仍为2,000,000,000股普通股、每股面值USD 0.0001，对应总额USD 200,000。报告期内，普通股由上月底的1,298,233,804股增至1,298,413,056股，增加179,252股，库藏股数目保持为0。截至2026年5月31日，公司确认满足香港联交所关于公众持股量的相关要求。该公告由公司董事梁朋代表董事会签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cloverbiopharma.com","stockEarnings":[{"period":"1week","weight":0.0816},{"period":"1month","weight":-0.0681},{"period":"3month","weight":0.2254},{"period":"6month","weight":-0.2535},{"period":"1year","weight":-0.0783},{"period":"ytd","weight":-0.094}],"compareEarnings":[{"period":"1week","weight":0.0049},{"period":"1month","weight":-0.0268},{"period":"3month","weight":0.0761},{"period":"6month","weight":-0.0047},{"period":"1year","weight":-0.0507},{"period":"ytd","weight":-0.0311}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"三叶草生物制药有限公司是一家主要从事创新型疫苗的研发、生产和商业化的投资控股公司。该公司的产品及候选疫苗包括呼吸道合胞病毒（RSV）疫苗（SCB-1019）、四价季节性流感疫苗AdimFlu-S、SCB-219M、新冠疫苗等。该公司依托Trimer-Tag技术平台开展可解决未满足需求的创新疫苗的研发（R&D），专注于建立呼吸道疫苗专营权，并在儿科疫苗市场创立业务。Trimer-Tag技术平台是一个基于天然依赖三聚体化功能的靶点用于研制重组蛋白疫苗的产品开发平台。该公司在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.113925},{"month":2,"riseRate":0.4,"avgChangeRate":0.011169},{"month":3,"riseRate":0.2,"avgChangeRate":-0.104268},{"month":4,"riseRate":0.4,"avgChangeRate":-0.028136},{"month":5,"riseRate":0.4,"avgChangeRate":-0.154826},{"month":6,"riseRate":0.4,"avgChangeRate":-0.025093},{"month":7,"riseRate":0.6,"avgChangeRate":0.169081},{"month":8,"riseRate":0.6,"avgChangeRate":0.078417},{"month":9,"riseRate":0.6,"avgChangeRate":0.265634},{"month":10,"riseRate":0,"avgChangeRate":-0.070872},{"month":11,"riseRate":0.75,"avgChangeRate":0.569272},{"month":12,"riseRate":0.2,"avgChangeRate":-0.160916}],"exchange":"SEHK","name":"三叶草生物-B","nameEN":"CLOVER BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三叶草生物-B(02197)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三叶草生物-B,02197,三叶草生物-B股票,三叶草生物-B股票老虎,三叶草生物-B股票老虎国际,三叶草生物-B行情,三叶草生物-B股票行情,三叶草生物-B股价,三叶草生物-B股市,三叶草生物-B股票价格,三叶草生物-B股票交易,三叶草生物-B股票购买,三叶草生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三叶草生物-B(02197)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}